IDX vs NUZ

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

IDX

INTEG DIAG FPO [IDX]

52MEDIUM

NUZ

NEURITHERA FPO [NUZ]

41LOW

Score Breakdown

IDX NUZ
Technical
40
48
Catalyst
58
53
Sentiment
50
50
Fundamental
100
43
Momentum
43
36
Risk Gate
34
50

Key Metrics

IDX Metric NUZ
$776.0MMarket Cap$51.2M
872KAvg Volume (20d)1.1M
+1.4%Short InterestN/A
$3.07052-Week High$0.185
$1.90552-Week Low$0.055
-0.5%Daily Change-3.0%
$2.070Reference Price$0.065
+2.1%ROE-147.1%
+1.8%Profit Margin-248.4%

Active Signals

IDX Signals

●Stochastic turning bearish from a high level — caution
●Knocking on the door of resistance — if it punches through, things could get interesting
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.0x)
●Strong revenue growth (+56%)
●EPS estimates revised upward (+10pts)

NUZ Signals

●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.8 quarters)
●Moderate P/S ratio (8.6x)
●Strong revenue growth (+290%)
●Near 52-week low (9% of range)
●Small-cap ($20-100M)
●Capital raise activity (1 events)
●Deeply negative margins (-248%)

Ask Scout AI to compare IDX and NUZ in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IDX vs PCK →IDX vs PEB →IDX vs RCE →IDX vs SNT →IDX vs TRJ →
IDX Full Analysis → NUZ Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).